Skip to main content

Related Insights

Venture-Backed Biotech Funding increasingly Accounts for Regulatory Pathway Complexity

Venture-Backed Biotech Funding increasingly Accounts for Regulatory Pathway Complexity

: Large funding rounds at venture-backed biotech companies such as Khartis and InduPro show how regulatory pathway complexity is becoming an important consideration in early capital planning. Investors and management teams increasingly need to account for clinical development, regulatory milestones and manufacturing requirements when determining how much capital a new drug program may require.

EUDR Enforcement After June 30: What Palm Chemical Buyers Must Do in Early July 2026

EUDR Enforcement After June 30: What Palm Chemical Buyers Must Do in Early July 2026

After full enforcement of the EU Deforestation‑Free Products Regulation on July 1, 2026, palm‑derived chemical buyers must prove their supply chains are deforestation‑free. This article outlines the key compliance steps for fatty acids, glycerin, oleic acid and CAPB precursors sourced from Indonesia and Malaysia. Learn how to audit, document and secure your EU market access today.

Don't miss out on our updates! Subscribe to our newsletter now

We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.